Xiaofan Li

731 total citations
17 papers, 508 citations indexed

About

Xiaofan Li is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Xiaofan Li has authored 17 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Xiaofan Li's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Click Chemistry and Applications (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Xiaofan Li is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Click Chemistry and Applications (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Xiaofan Li collaborates with scholars based in United States, China and Jordan. Xiaofan Li's co-authors include Trevor J. Hallam, Aaron K. Sato, Gang Yin, Alice Yam, Cuong Tran, Tyler H. Heibeck, Alexander Steiner, Erik S. Zimmerman, Avinash Gill and Kalyani Penta and has published in prestigious journals such as Blood, Cancer Research and Journal of Neurophysiology.

In The Last Decade

Xiaofan Li

16 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofan Li United States 10 274 257 219 104 43 17 508
Remon van Geel Netherlands 8 289 1.1× 365 1.4× 193 0.9× 270 2.6× 16 0.4× 9 579
Nicola Ashman United Kingdom 6 265 1.0× 202 0.8× 273 1.2× 130 1.3× 8 0.2× 8 456
Erik D. Wold United States 8 226 0.8× 351 1.4× 158 0.7× 155 1.5× 9 0.2× 10 498
Lucía De Rosa Italy 14 70 0.3× 314 1.2× 73 0.3× 138 1.3× 10 0.2× 37 442
Adam D. Cotton United States 5 75 0.3× 505 2.0× 284 1.3× 38 0.4× 13 0.3× 6 605
Lesley Jones United Kingdom 7 290 1.1× 312 1.2× 263 1.2× 167 1.6× 16 0.4× 8 485
Robert J. Goodson United States 7 93 0.3× 228 0.9× 74 0.3× 27 0.3× 16 0.4× 11 391
Jason R. Porter United States 12 111 0.4× 457 1.8× 45 0.2× 95 0.9× 13 0.3× 13 662
D. Y. JACKSON United States 5 123 0.4× 263 1.0× 47 0.2× 78 0.8× 14 0.3× 5 349
Salvatore Demartis Italy 10 212 0.8× 259 1.0× 54 0.2× 107 1.0× 16 0.4× 11 433

Countries citing papers authored by Xiaofan Li

Since Specialization
Citations

This map shows the geographic impact of Xiaofan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofan Li more than expected).

Fields of papers citing papers by Xiaofan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofan Li. The network helps show where Xiaofan Li may publish in the future.

Co-authorship network of co-authors of Xiaofan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofan Li. A scholar is included among the top collaborators of Xiaofan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofan Li. Xiaofan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Xiaofan, Cristina L. Abrahams, Abigail Yu, et al.. (2023). Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget. 14(1). 1–13. 5 indexed citations
2.
Yam, Alice, Helena Kiefel, Andrew McGeehan, et al.. (2023). Abstract 4894: The anti-ROR1 ADC STRO-003 demonstrates immune-modulating properties that may enhance checkpoint blockade. Cancer Research. 83(7_Supplement). 4894–4894. 1 indexed citations
3.
Polyakov, Valery, et al.. (2022). Indexing Ultrafast Shape-Based Descriptors in MongoDB to Identify TLR4 Pathway Agonists. Journal of Chemical Information and Modeling. 62(10). 2446–2455. 2 indexed citations
4.
Zhou, Qingli, et al.. (2022). Electron donor–acceptor complex-catalyzed photoredox reactions mediated by DIPEA and inorganic carbonates. Organic Chemistry Frontiers. 9(19). 5264–5271. 21 indexed citations
5.
Li, Xiaofan, et al.. (2021). Malformin C, an algicidal peptide from marine fungus Aspergillus species. Ecotoxicology. 30(5). 996–1003. 5 indexed citations
6.
Groff, Dan, Jeffrey Hanson, Sheng-Wen Liang, et al.. (2021). Development of an E. coli strain for cell‐free ADC manufacturing. Biotechnology and Bioengineering. 119(1). 162–175. 12 indexed citations
7.
Almaliti, Jehad, Bailey W. Miller, Halina Pietraszkiewicz, et al.. (2018). Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents. European Journal of Medicinal Chemistry. 161. 416–432. 32 indexed citations
8.
Abrahams, Cristina L., Xiaofan Li, Millicent Embry, et al.. (2018). Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001. Oncotarget. 9(102). 37700–37714. 45 indexed citations
9.
Spangler, Benjamin, Toni Kline, Jeffrey Hanson, et al.. (2018). Toward a Ferrous Iron-Cleavable Linker for Antibody–Drug Conjugates. Molecular Pharmaceutics. 15(5). 2054–2059. 16 indexed citations
10.
Zhao, Shuchun, et al.. (2018). High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti‐CD74‐drug conjugate. The Journal of Pathology Clinical Research. 5(1). 12–24. 20 indexed citations
11.
12.
Embry, Millicent, Xiaofan Li, Abigail Yu, et al.. (2017). CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001. Blood. 130. 4420–4420. 1 indexed citations
13.
Xu, Yiren, Guifeng Jiang, Cuong Tran, et al.. (2016). RP-HPLC DAR Characterization of Site-Specific Antibody Drug Conjugates Produced in a Cell-Free Expression System. Organic Process Research & Development. 20(6). 1034–1043. 27 indexed citations
14.
Tang, Jianqiang, Zhiqin Wu, Xiaofan Li, et al.. (2015). A novel cyclic dipeptide from deep marine-derived fungus Aspergillus sp. SCSIOW2. Natural Product Research. 30(1). 52–57. 26 indexed citations
15.
Zimmerman, Erik S., Tyler H. Heibeck, Avinash Gill, et al.. (2014). Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System. Bioconjugate Chemistry. 25(2). 351–361. 277 indexed citations
16.
Arai, Midori A., et al.. (2010). Total synthesis and evaluation of Wnt signal inhibition of melleumin A and B, and their derivatives. Organic & Biomolecular Chemistry. 8(23). 5285–93. 5 indexed citations
17.
Cook, David G., et al.. (2005). Presenilin 1 Deficiency Alters the Activity of Voltage-Gated Ca2+Channels in Cultured Cortical Neurons. Journal of Neurophysiology. 94(6). 4421–4429. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Remon van Geel Breakdown of academic impact, for papers by Nicola Ashman Breakdown of academic impact, for papers by Erik D. Wold Breakdown of academic impact, for papers by Lucía De Rosa Breakdown of academic impact, for papers by Adam D. Cotton Breakdown of academic impact, for papers by Lesley Jones Breakdown of academic impact, for papers by Robert J. Goodson Breakdown of academic impact, for papers by Jason R. Porter Breakdown of academic impact, for papers by D. Y. JACKSON Breakdown of academic impact, for papers by Salvatore Demartis
Rankless by CCL
2026